Frailty and P2Y12 Inhibitors: Does The Best Approach Need to Be Black or White?
Am J Cardiol
.
2024 Feb 15:213:186.
doi: 10.1016/j.amjcard.2023.12.026.
Epub 2023 Dec 22.
Authors
Iñigo Lozano
1
,
Jose M Vegas
2
,
Juan Rondan
2
Affiliations
1
Department of Cardiology, Hospital Cabueñes, Gijón, Spain. Electronic address: inigo.lozano@gmail.com.
2
Department of Cardiology, Hospital Cabueñes, Gijón, Spain.
PMID:
38142879
DOI:
10.1016/j.amjcard.2023.12.026
No abstract available
Publication types
Letter
MeSH terms
Clopidogrel
Frailty*
Humans
Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists / therapeutic use
Substances
Platelet Aggregation Inhibitors
Clopidogrel
Purinergic P2Y Receptor Antagonists